Company Filing History:
Years Active: 1989
Title: Innovations of Katsuyoshi Shigeta
Introduction
Katsuyoshi Shigeta is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Katsuyoshi Shigeta holds a patent for "Monoclonal antibodies specific for synthetic glycosphingolipids having - Hybridomas which produce monoclonal antibodies specific to an abnormal branched determinant of a synthetic glycolipid antigen and methods of use of the monoclonal antibodies." This patent highlights his expertise in creating targeted therapies that can potentially improve treatment outcomes.
Career Highlights
Shigeta is associated with Mect Corporation, where he continues to advance his research and development efforts. His work at the company emphasizes the integration of scientific research with practical applications in the medical field.
Collaborations
Throughout his career, Katsuyoshi Shigeta has collaborated with notable colleagues, including Reiji Kannagi and Yukishige Ito. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Katsuyoshi Shigeta's contributions to the field of biotechnology through his patents and collaborations underscore the vital role of inventors in advancing medical science. His work exemplifies the impact of innovation on healthcare solutions.